I. Juhan-Vague

1.2k total citations
26 papers, 868 citations indexed

About

I. Juhan-Vague is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, I. Juhan-Vague has authored 26 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Hematology. Recurrent topics in I. Juhan-Vague's work include Blood properties and coagulation (5 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Atrial Fibrillation Management and Outcomes (3 papers). I. Juhan-Vague is often cited by papers focused on Blood properties and coagulation (5 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Atrial Fibrillation Management and Outcomes (3 papers). I. Juhan-Vague collaborates with scholars based in France, Belgium and Slovenia. I. Juhan-Vague's co-authors include Marie‐Christine Alessi, Pierre‐Emmanuel Morange, Alenka Mavri, Delphine Bastelica, Monique Verdier, Isabelle Leduc, B Berthet, Désiré Collen, J. Gouvernet and Jean‐François Renucci and has published in prestigious journals such as Diabetes, Arteriosclerosis Thrombosis and Vascular Biology and Infection and Immunity.

In The Last Decade

I. Juhan-Vague

26 papers receiving 827 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Juhan-Vague France 11 317 190 173 172 171 26 868
Franco Carmassi Italy 12 145 0.5× 130 0.7× 194 1.1× 133 0.8× 63 0.4× 34 739
C. Kluft Netherlands 15 103 0.3× 251 1.3× 125 0.7× 209 1.2× 66 0.4× 35 751
Hajime Tsuji Japan 18 146 0.5× 399 2.1× 334 1.9× 88 0.5× 100 0.6× 70 992
Kaoru Takemura Japan 6 517 1.6× 51 0.3× 223 1.3× 108 0.6× 322 1.9× 10 988
Noemi Michetti Italy 9 124 0.4× 184 1.0× 123 0.7× 64 0.4× 103 0.6× 11 612
Débora C. Souza-Costa Brazil 16 88 0.3× 82 0.4× 288 1.7× 106 0.6× 322 1.9× 23 843
Jerome I. Brody United States 19 98 0.3× 316 1.7× 151 0.9× 115 0.7× 101 0.6× 76 1.1k
Ferdinando De Negri Italy 15 113 0.4× 79 0.4× 141 0.8× 111 0.6× 32 0.2× 40 762
Linda Woolf United Kingdom 6 76 0.2× 426 2.2× 210 1.2× 201 1.2× 63 0.4× 7 853
Marco Morale Italy 8 121 0.4× 80 0.4× 153 0.9× 88 0.5× 37 0.2× 14 484

Countries citing papers authored by I. Juhan-Vague

Since Specialization
Citations

This map shows the geographic impact of I. Juhan-Vague's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Juhan-Vague with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Juhan-Vague more than expected).

Fields of papers citing papers by I. Juhan-Vague

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Juhan-Vague. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Juhan-Vague. The network helps show where I. Juhan-Vague may publish in the future.

Co-authorship network of co-authors of I. Juhan-Vague

This figure shows the co-authorship network connecting the top 25 collaborators of I. Juhan-Vague. A scholar is included among the top collaborators of I. Juhan-Vague based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Juhan-Vague. I. Juhan-Vague is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Juhan-Vague, I., Marie‐Christine Alessi, Alenka Mavri, & Pierre‐Emmanuel Morange. (2003). Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk. Journal of Thrombosis and Haemostasis. 1(7). 1575–1579. 277 indexed citations
2.
Aubert, H., M. Henry, Pierre‐Emmanuel Morange, et al.. (2001). Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphisms. Human Genetics. 109(2). 191–197. 31 indexed citations
3.
Alessi, Marie‐Christine, Delphine Bastelica, Pierre‐Emmanuel Morange, et al.. (2000). Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.. Diabetes. 49(8). 1374–1380. 275 indexed citations
4.
Juhan-Vague, I., et al.. (1998). Activation of coagulation in decompression illness.. PubMed. 69(2). 129–32. 19 indexed citations
5.
Fossat, C., David Fabre, Yves Alimi, et al.. (1995). Leukocyte Activation Study During Occlusive Arterial Disease of the Lower Limb. Journal of Cardiovascular Pharmacology. 25. S96–S100. 15 indexed citations
6.
Ambrosi, Pı̈erre & I. Juhan-Vague. (1995). [Dyslipidemia, lipid lowering drugs and thrombosis].. PubMed. 88(11). 1641–5. 5 indexed citations
7.
Bory, M, et al.. (1992). [Lipid indicators of vascular risk. A cross-sectional study of a group of coronary patients, a group of subjects with normal coronary angiography and a control group].. PubMed. 41(2). 87–91. 1 indexed citations
8.
Chauvet, Véronique, et al.. (1991). Anévrysme de l'aorte abdominale et coagulation intravasculaire préopératoire. Annales Françaises d Anesthésie et de Réanimation. 10(2). 164–167. 1 indexed citations
9.
Camboulives, J, et al.. (1991). [Disseminated intravascular coagulation masking neonatal hemophilia].. PubMed. 38(3). 185–8. 2 indexed citations
10.
11.
Élias, Antoine, et al.. (1990). Assessment of D-dimer measurement by ELISA or latex methods in deep vein thrombosis diagnosed by ultrasonic duplex scanning. Fibrinolysis and Proteolysis. 4(4). 237–240. 19 indexed citations
12.
Roul, C., et al.. (1988). [The effect of pentoxifylline and propentofylline on the membrane fluidity of red blood cells in uncontrolled insulin-dependent (type 1) diabetic patients].. PubMed. 36(8 Pt 2). 1081–3. 2 indexed citations
13.
Juhan-Vague, I., Antoine Élias, M.F. Aillaud, et al.. (1988). Treatment of deep vein thrombosis with a very low molecular weight heparin (CY 222 - Choay): Thrombolysis and plasma fibrinolytic parameters. Fibrinolysis and Proteolysis. 2(1). 25–29. 4 indexed citations
14.
Collen, Désiré & I. Juhan-Vague. (1988). Fibrinolysis and Atherosclerosis. Seminars in Thrombosis and Hemostasis. 14(2). 180–183. 54 indexed citations
15.
16.
Juhan-Vague, I., Jean Marie Stassen, Marie‐Christine Alessi, L Kieckens, & Désiré Collen. (1987). EFFECT OF DIFFERENT HEPARINS ON THROMBOLYSIS WITH t-PA AND scu-PA IN RABBITS WITH EXPERIMENTAL THROMBOSIS. Thrombosis and Haemostasis. 1 indexed citations
17.
Juhan-Vague, I., et al.. (1986). [Thromboembolic disease and anomalies of fibrinolysis].. PubMed. 137(6). 471–4. 2 indexed citations
18.
Amiral, Jean, et al.. (1985). [Immunologic determination of the protein C of coagulation: detection of deficiencies].. PubMed. 43(6). 867–71. 2 indexed citations
19.
Juhan-Vague, I., et al.. (1984). Effect of 24 Hours of Normoglycaemia on Tissue-Type Plasminogen Activator Plasma Levels in Insulin Dependent Diabetes. Thrombosis and Haemostasis. 51(1). 97–98. 20 indexed citations
20.
Stuart, J., et al.. (1984). Anticoagulants and erythrocyte filterability. Biorheology. 23(s1). 279–281. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Franco Carmassi Breakdown of academic impact, for papers by C. Kluft Breakdown of academic impact, for papers by Hajime Tsuji Breakdown of academic impact, for papers by Kaoru Takemura Breakdown of academic impact, for papers by Noemi Michetti Breakdown of academic impact, for papers by Débora C. Souza-Costa Breakdown of academic impact, for papers by Jerome I. Brody Breakdown of academic impact, for papers by Ferdinando De Negri Breakdown of academic impact, for papers by Linda Woolf Breakdown of academic impact, for papers by Marco Morale
Rankless by CCL
2026